Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis
Clinical trial NCT03483012 · COMPLETED
Trial details
- NCT number
- NCT03483012
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2019-11-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.